PRIORITIES OF EARLY PATHOGENETIC THERAPY OF FLUE AND SARS OF OTHER ETIOLOGY
The prevalence of influenza and acute respiratory viral infections, high frequency of complications with a high mortality rate in certain groups of the population, short duration of specific immunity and the lack of efficiency of use of antiviral drugs for the treatment of patients make the problem...
Main Authors: | V. V. TSVETKOV, G. S. GOLOBOKOV |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1568 |
Similar Items
-
Combination therapy for acute respiratory viral infections from the perspective of a clinical pharmacologist
by: N. G. Berdnikova
Published: (2018-04-01) -
Interferon-gamma in the treatment of influenza and other respiratory viral infections
by: T. V. Sologub, et al.
Published: (2015-12-01) -
DIABETIC NEUROPATHY: MOLECULAR MECHANISMS OF DEVELOPMENT AND POSSIBILITIES FOR PATHOGENETIC THERAPY
by: Hudiakova N.V., et al.
Published: (2019-04-01) -
Modern View on the Pathogenetic Therapy of Diabetic Polyneuropathy
by: N.O. Pertseva, et al.
Published: (2014-10-01) -
MODERN APPROACHES TO THERAPY OF ACUTE RESPIRATORY VIRAL INFECTIONS OF THE UPPER RESPIRATORY TRACT
by: N. V. Orlova, et al.
Published: (2017-12-01)